DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 95 filers reported holding DYNE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $249,312 | -34.1% | 27,825 | -17.3% | 0.00% | – |
| Q2 2023 | $378,529 | +38.5% | 33,647 | +41.9% | 0.00% | – |
| Q1 2023 | $273,208 | +28.2% | 23,716 | +28.9% | 0.00% | – |
| Q4 2022 | $213,176 | -7.7% | 18,393 | +1.3% | 0.00% | – |
| Q3 2022 | $231,000 | +86.3% | 18,162 | +0.8% | 0.00% | – |
| Q2 2022 | $124,000 | -20.5% | 18,015 | +10.6% | 0.00% | – |
| Q1 2022 | $156,000 | -23.5% | 16,286 | -5.3% | 0.00% | – |
| Q4 2021 | $204,000 | -11.3% | 17,204 | +21.3% | 0.00% | – |
| Q3 2021 | $230,000 | -0.4% | 14,182 | +28.9% | 0.00% | – |
| Q2 2021 | $231,000 | -84.6% | 11,006 | -88.6% | 0.00% | -100.0% |
| Q1 2021 | $1,502,000 | +92.3% | 96,717 | +160.0% | 0.00% | – |
| Q4 2020 | $781,000 | +123.1% | 37,197 | +114.4% | 0.00% | – |
| Q3 2020 | $350,000 | – | 17,352 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,960,046 | $35,195,000 | 13.16% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $58,871,000 | 12.72% |
| Atlas Venture Life Science Advisors, LLC | 8,934,902 | $106,236,000 | 9.76% |
| Logos Global Management LP | 3,234,392 | $38,457,000 | 3.97% |
| GREAT POINT PARTNERS LLC | 845,000 | $10,047,000 | 2.23% |
| Deep Track Capital, LP | 2,292,250 | $27,255,000 | 1.92% |
| Octagon Capital Advisors LP | 583,649 | $6,940,000 | 1.35% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 476,000 | $5,641,000 | 1.26% |
| COMMODORE CAPITAL LP | 305,125 | $3,628,000 | 0.84% |
| RA Capital Management | 2,805,045 | $33,352,000 | 0.59% |